SlideShare une entreprise Scribd logo
1  sur  15
From PB14–15 to PB16–17:
Regional plan for
implementation
Imre Hollo
Director, Administration and Finance
PB14–15: summary
• Approved PB US$ 225 million (108% funded)
• Allocated PB US$ 253 million, of which US$ 23 million in
Emergencies (99% funded)
What was new in PB14–15?
• PB approved in its entirety
• Financing dialogue
• Corporate resources used strategically
How PB14–15 has been different
for the Regional Office
• 9% greater share of corporate resources than in PB12–13
• As a result, greater flexibility and more even level of
category funding; fewer “pockets of poverty”
• 10% lower staff costs than in PB12–13 due to
sustainability exercise; no salary gap
PB14–15 challenges
• PB implementation currently below expectations
• timing of resource availability and slow implementation Jan-Mar 2014
• Ebola emergency response
• impact of a stronger USD
• lower staff expenditures
• Secretariat is taking measures and implementation rate is
increasing
From 2014–15 to 2016–17
• Continuity of priorities, aiming at 10 outcomes
• Realistic budget
• Continued programmatic and budgetary accountability of
the Regional Office to Member States  new iteration of
the “contract”
PB16–17: continuity of priorities
• Defined through in-depth bottom-up planning exercise
• Included governing bodies resolutions
• Guided by Health 2020
• In line with global priority-setting
• Built on lessons learned (e.g. from Ebola response)
PB16–17: continuity of priorities
• Scaling up AMR and hepatitis
• Greater emphasis and resource in NCDs
• Continue strengthening health systems
• Strengthening institutional capacity in emergency risk
and crisis management
• Strengthening country presence
PB16–17: realistic budget
• Bottom-up planning laid
solid foundation
• Adjustments made to
reflect global priorities
• Resulting budget in line
– with allocated PB14-15 (also
for majority of categories)
– PB14-15 funding
realistic budget 2016-17
-
10
20
30
40
50
60
1 2 3 4 5 6
US$millions
Category (Base only)
WHA PB14-15 Current allocations PB14-15 WHA PB16-17 Funds available
PB16–17 “Contract”
• Grounded in WHA-approved PB16–17 but details the
European contribution to the global results chain –
What will we do to achieve the results?
• Presents European Region’s contribution to the global
indicators of the PB16–17 – How the achievements will
be measured?
• Outcomes and outcome indicators
 Joint responsibility of the Member States and the Secretariat
• Outputs and output indicators
 Managerial responsibility of the Secretariat
PB16–17 “Contract”
PB16–17 “Contract” outcome indicators
Results
chain
Title
Global
indicator:
baseline
Global
indicator:
target
Regional
indicator:
baseline
Regional
indicator:
target
Indicator details
Outcome
indicator
Number of countries reporting on national health
workforce disaggregation (by top 10 cadres, place of
employment, urban/rural, subnational administrative
area (second level))
0/194
(2015)
50/194
(2017)
0/53
(2015)
25/53
(2017)
Data reported by Member
States on health workforce
employment and education to
the Joint OECD/Eurostat/WHO
Europe database (excluding
second-level data).
Global PB 2016–2017 results structure: Category 4. Health systems Contribution of the European Region
joint responsibility
Results
chain
Title
Global
indicator:
baseline
Global
indicator:
target
Regional
indicator:
baseline
Regional
indicator:
target
Indicator details
Output
4.2.1. Equitable integrated, people-centred service
delivery systems in place in countries and public health
approaches strengthened
Output
indicator
Number of countries enabled to implement integrated,
people-centred health service strategies through
different models of care delivery matched with their
infrastructure, capacities and other resources
48/194 83/194 15/53 16/53
Global PB 2016–2017 results structure: Category 4. Health systems Contribution of the European Region
PB16–17 “Contract” output indicators
Responsibility of the Secretariat
PB16–17 “Contract”
Full text of the “contract” by category and programme area
with outcome and output indicators:
EUR/RC65/Inf.Doc./1 “Regional plan for implementation of
programme budget 2016–2017 by category in the WHO
European Region”
Thank you

Contenu connexe

Similaire à From PB14–15 to PB16–17: Regional plan for implementation

Draft proposed programme budget 2016–2017: the European regional perspective
Draft proposed programme budget 2016–2017:the European regional perspectiveDraft proposed programme budget 2016–2017:the European regional perspective
Draft proposed programme budget 2016–2017: the European regional perspectiveWHO Regional Office for Europe
 
May 26, 2016 City of Corona Budget Workshop Presentation
May 26, 2016 City of Corona Budget Workshop PresentationMay 26, 2016 City of Corona Budget Workshop Presentation
May 26, 2016 City of Corona Budget Workshop PresentationCity of Corona
 
Final City of Corona - Budget Study Session
Final City of Corona - Budget Study SessionFinal City of Corona - Budget Study Session
Final City of Corona - Budget Study SessionCity of Corona
 
Public Budget Analysis Project: Queensland, Australia
Public Budget Analysis Project: Queensland, AustraliaPublic Budget Analysis Project: Queensland, Australia
Public Budget Analysis Project: Queensland, AustraliaRaul A. Lujan Anaya
 
Fiscal space and the composition of public finances - Christian Kastrop, OECD
Fiscal space and the composition of public finances - Christian Kastrop, OECDFiscal space and the composition of public finances - Christian Kastrop, OECD
Fiscal space and the composition of public finances - Christian Kastrop, OECDOECD Governance
 
Fiscal space and the composition of public finances - Christian Kastrop, OECD
Fiscal space and the composition of public finances - Christian Kastrop, OECDFiscal space and the composition of public finances - Christian Kastrop, OECD
Fiscal space and the composition of public finances - Christian Kastrop, OECDOECD Governance
 
Centre for policy dialogue cpd analysis national budget fy2015 16 june 2015
Centre for policy dialogue cpd analysis national budget fy2015 16 june 2015Centre for policy dialogue cpd analysis national budget fy2015 16 june 2015
Centre for policy dialogue cpd analysis national budget fy2015 16 june 2015Centre for Policy Dialogue (CPD)
 
Philippine fiscal and expenditure management reforms - Rolando Toledo - Phili...
Philippine fiscal and expenditure management reforms - Rolando Toledo - Phili...Philippine fiscal and expenditure management reforms - Rolando Toledo - Phili...
Philippine fiscal and expenditure management reforms - Rolando Toledo - Phili...OECD Governance
 
Day2 sp4 pres-washington_elettore_en
Day2 sp4 pres-washington_elettore_enDay2 sp4 pres-washington_elettore_en
Day2 sp4 pres-washington_elettore_enicgfmconference
 
Demographic Change and Expenditure Pressures in Ireland
Demographic Change and Expenditure Pressures in IrelandDemographic Change and Expenditure Pressures in Ireland
Demographic Change and Expenditure Pressures in IrelandDaragh McCarthy
 
1.1._vanina_albanian_pfm_reform_indicators.pptx
1.1._vanina_albanian_pfm_reform_indicators.pptx1.1._vanina_albanian_pfm_reform_indicators.pptx
1.1._vanina_albanian_pfm_reform_indicators.pptxMahmoud998660
 
Regional plan for implementation (RPI) of programme budget (PB) 2018–2019 in ...
Regional plan for implementation (RPI) of programme budget (PB) 2018–2019 in ...Regional plan for implementation (RPI) of programme budget (PB) 2018–2019 in ...
Regional plan for implementation (RPI) of programme budget (PB) 2018–2019 in ...WHO Regional Office for Europe
 
Performance budgeting: United Kingdom experience, Julian Kelly, United Kingdom
Performance budgeting: United Kingdom experience, Julian Kelly, United KingdomPerformance budgeting: United Kingdom experience, Julian Kelly, United Kingdom
Performance budgeting: United Kingdom experience, Julian Kelly, United KingdomOECD Governance
 

Similaire à From PB14–15 to PB16–17: Regional plan for implementation (20)

Draft proposed programme budget 2016–2017: the European regional perspective
Draft proposed programme budget 2016–2017:the European regional perspectiveDraft proposed programme budget 2016–2017:the European regional perspective
Draft proposed programme budget 2016–2017: the European regional perspective
 
May 26, 2016 City of Corona Budget Workshop Presentation
May 26, 2016 City of Corona Budget Workshop PresentationMay 26, 2016 City of Corona Budget Workshop Presentation
May 26, 2016 City of Corona Budget Workshop Presentation
 
Final City of Corona - Budget Study Session
Final City of Corona - Budget Study SessionFinal City of Corona - Budget Study Session
Final City of Corona - Budget Study Session
 
CPD Dialogue on Analysis of the National Budget FY2016
CPD Dialogue on Analysis of the National Budget FY2016CPD Dialogue on Analysis of the National Budget FY2016
CPD Dialogue on Analysis of the National Budget FY2016
 
Public Budget Analysis Project: Queensland, Australia
Public Budget Analysis Project: Queensland, AustraliaPublic Budget Analysis Project: Queensland, Australia
Public Budget Analysis Project: Queensland, Australia
 
Fiscal space and the composition of public finances - Christian Kastrop, OECD
Fiscal space and the composition of public finances - Christian Kastrop, OECDFiscal space and the composition of public finances - Christian Kastrop, OECD
Fiscal space and the composition of public finances - Christian Kastrop, OECD
 
Fiscal space and the composition of public finances - Christian Kastrop, OECD
Fiscal space and the composition of public finances - Christian Kastrop, OECDFiscal space and the composition of public finances - Christian Kastrop, OECD
Fiscal space and the composition of public finances - Christian Kastrop, OECD
 
Centre for policy dialogue cpd analysis national budget fy2015 16 june 2015
Centre for policy dialogue cpd analysis national budget fy2015 16 june 2015Centre for policy dialogue cpd analysis national budget fy2015 16 june 2015
Centre for policy dialogue cpd analysis national budget fy2015 16 june 2015
 
Philippine fiscal and expenditure management reforms - Rolando Toledo - Phili...
Philippine fiscal and expenditure management reforms - Rolando Toledo - Phili...Philippine fiscal and expenditure management reforms - Rolando Toledo - Phili...
Philippine fiscal and expenditure management reforms - Rolando Toledo - Phili...
 
A Great Opportunity for Fiscal Transparency
A Great Opportunity for Fiscal TransparencyA Great Opportunity for Fiscal Transparency
A Great Opportunity for Fiscal Transparency
 
Budget analysis of Bangladesh of Fiscal Year 2016-17
Budget analysis of Bangladesh of Fiscal Year 2016-17Budget analysis of Bangladesh of Fiscal Year 2016-17
Budget analysis of Bangladesh of Fiscal Year 2016-17
 
Speech, Avdullah Hoti, SIGMA, Paris, 4 December 2015
Speech, Avdullah Hoti, SIGMA, Paris, 4 December 2015Speech, Avdullah Hoti, SIGMA, Paris, 4 December 2015
Speech, Avdullah Hoti, SIGMA, Paris, 4 December 2015
 
Day2 sp4 pres-washington_elettore_en
Day2 sp4 pres-washington_elettore_enDay2 sp4 pres-washington_elettore_en
Day2 sp4 pres-washington_elettore_en
 
The National Budget
The National BudgetThe National Budget
The National Budget
 
Demographic Change and Expenditure Pressures in Ireland
Demographic Change and Expenditure Pressures in IrelandDemographic Change and Expenditure Pressures in Ireland
Demographic Change and Expenditure Pressures in Ireland
 
1.1._vanina_albanian_pfm_reform_indicators.pptx
1.1._vanina_albanian_pfm_reform_indicators.pptx1.1._vanina_albanian_pfm_reform_indicators.pptx
1.1._vanina_albanian_pfm_reform_indicators.pptx
 
Regional plan for implementation (RPI) of programme budget (PB) 2018–2019 in ...
Regional plan for implementation (RPI) of programme budget (PB) 2018–2019 in ...Regional plan for implementation (RPI) of programme budget (PB) 2018–2019 in ...
Regional plan for implementation (RPI) of programme budget (PB) 2018–2019 in ...
 
Statement 14-39 en
Statement 14-39 enStatement 14-39 en
Statement 14-39 en
 
CPFF FAO_2.pptx
CPFF FAO_2.pptxCPFF FAO_2.pptx
CPFF FAO_2.pptx
 
Performance budgeting: United Kingdom experience, Julian Kelly, United Kingdom
Performance budgeting: United Kingdom experience, Julian Kelly, United KingdomPerformance budgeting: United Kingdom experience, Julian Kelly, United Kingdom
Performance budgeting: United Kingdom experience, Julian Kelly, United Kingdom
 

Plus de WHO Regional Office for Europe

EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...WHO Regional Office for Europe
 
Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022WHO Regional Office for Europe
 
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022WHO Regional Office for Europe
 
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...WHO Regional Office for Europe
 
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...WHO Regional Office for Europe
 
Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022WHO Regional Office for Europe
 
Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021WHO Regional Office for Europe
 
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...WHO Regional Office for Europe
 
Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.WHO Regional Office for Europe
 
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...WHO Regional Office for Europe
 

Plus de WHO Regional Office for Europe (20)

EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
 
Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022
 
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
 
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...
 
Epidata 3/2022
Epidata  3/2022Epidata  3/2022
Epidata 3/2022
 
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
 
Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022
 
EpiData 1/2022 Russian
EpiData 1/2022 RussianEpiData 1/2022 Russian
EpiData 1/2022 Russian
 
EpiData 1/2022
EpiData 1/2022EpiData 1/2022
EpiData 1/2022
 
EpiData 12/2021 Russian
EpiData 12/2021 RussianEpiData 12/2021 Russian
EpiData 12/2021 Russian
 
Epidata 12/2021
Epidata 12/2021Epidata 12/2021
Epidata 12/2021
 
Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021
 
Epidata 11/2021
Epidata 11/2021 Epidata 11/2021
Epidata 11/2021
 
EpiData 10/2021
EpiData 10/2021EpiData 10/2021
EpiData 10/2021
 
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
 
Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.
 
EpiData 8/2021
EpiData 8/2021EpiData 8/2021
EpiData 8/2021
 
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
 
EpiData 5/2021
EpiData 5/2021EpiData 5/2021
EpiData 5/2021
 
EpiData monthly 4/2021
EpiData monthly 4/2021EpiData monthly 4/2021
EpiData monthly 4/2021
 

Dernier

5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor rawSherrylee83
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examJunhao Koh
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Anjali Parmar
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMeenakshiGursamy
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionGolden Helix
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumassuser144901
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerSherrylee83
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Ayman Seddik
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDr.shiva sai vemula
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...marcuskenyatta275
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptxSabbu Khatoon
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Anjali Parmar
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale nowSherrylee83
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالةMohamad محمد Al-Gailani الكيلاني
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingMedicoseAcademics
 
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...marcuskenyatta275
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxDr KHALID B.M
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxSergio Pinski
 
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediatesBMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediatesdorademei
 

Dernier (20)

5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediatesBMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
 

From PB14–15 to PB16–17: Regional plan for implementation

  • 1. From PB14–15 to PB16–17: Regional plan for implementation Imre Hollo Director, Administration and Finance
  • 2. PB14–15: summary • Approved PB US$ 225 million (108% funded) • Allocated PB US$ 253 million, of which US$ 23 million in Emergencies (99% funded)
  • 3. What was new in PB14–15? • PB approved in its entirety • Financing dialogue • Corporate resources used strategically
  • 4. How PB14–15 has been different for the Regional Office • 9% greater share of corporate resources than in PB12–13 • As a result, greater flexibility and more even level of category funding; fewer “pockets of poverty” • 10% lower staff costs than in PB12–13 due to sustainability exercise; no salary gap
  • 5. PB14–15 challenges • PB implementation currently below expectations • timing of resource availability and slow implementation Jan-Mar 2014 • Ebola emergency response • impact of a stronger USD • lower staff expenditures • Secretariat is taking measures and implementation rate is increasing
  • 6. From 2014–15 to 2016–17 • Continuity of priorities, aiming at 10 outcomes • Realistic budget • Continued programmatic and budgetary accountability of the Regional Office to Member States  new iteration of the “contract”
  • 7. PB16–17: continuity of priorities • Defined through in-depth bottom-up planning exercise • Included governing bodies resolutions • Guided by Health 2020 • In line with global priority-setting • Built on lessons learned (e.g. from Ebola response)
  • 8. PB16–17: continuity of priorities • Scaling up AMR and hepatitis • Greater emphasis and resource in NCDs • Continue strengthening health systems • Strengthening institutional capacity in emergency risk and crisis management • Strengthening country presence
  • 9. PB16–17: realistic budget • Bottom-up planning laid solid foundation • Adjustments made to reflect global priorities • Resulting budget in line – with allocated PB14-15 (also for majority of categories) – PB14-15 funding realistic budget 2016-17 - 10 20 30 40 50 60 1 2 3 4 5 6 US$millions Category (Base only) WHA PB14-15 Current allocations PB14-15 WHA PB16-17 Funds available
  • 10. PB16–17 “Contract” • Grounded in WHA-approved PB16–17 but details the European contribution to the global results chain – What will we do to achieve the results? • Presents European Region’s contribution to the global indicators of the PB16–17 – How the achievements will be measured?
  • 11. • Outcomes and outcome indicators  Joint responsibility of the Member States and the Secretariat • Outputs and output indicators  Managerial responsibility of the Secretariat PB16–17 “Contract”
  • 12. PB16–17 “Contract” outcome indicators Results chain Title Global indicator: baseline Global indicator: target Regional indicator: baseline Regional indicator: target Indicator details Outcome indicator Number of countries reporting on national health workforce disaggregation (by top 10 cadres, place of employment, urban/rural, subnational administrative area (second level)) 0/194 (2015) 50/194 (2017) 0/53 (2015) 25/53 (2017) Data reported by Member States on health workforce employment and education to the Joint OECD/Eurostat/WHO Europe database (excluding second-level data). Global PB 2016–2017 results structure: Category 4. Health systems Contribution of the European Region joint responsibility
  • 13. Results chain Title Global indicator: baseline Global indicator: target Regional indicator: baseline Regional indicator: target Indicator details Output 4.2.1. Equitable integrated, people-centred service delivery systems in place in countries and public health approaches strengthened Output indicator Number of countries enabled to implement integrated, people-centred health service strategies through different models of care delivery matched with their infrastructure, capacities and other resources 48/194 83/194 15/53 16/53 Global PB 2016–2017 results structure: Category 4. Health systems Contribution of the European Region PB16–17 “Contract” output indicators Responsibility of the Secretariat
  • 14. PB16–17 “Contract” Full text of the “contract” by category and programme area with outcome and output indicators: EUR/RC65/Inf.Doc./1 “Regional plan for implementation of programme budget 2016–2017 by category in the WHO European Region”